Articles

The need for better AD animal models

in Neuropharmacology

• Miguel Medina
• Jesús Avila

Proteomic Identification of Pathways Responsible for the Estradiol Therapeutic Window in AD Animal Models

in Cellular Neuropathology

• Jie Cui
• Jon Reed
• Gogce Crynen
• Ghania Ait-Ghezala
• Fiona Crawford
• Yong Shen
• Rena Li

Sex Differences in the Cognitive and Hippocampal Effects of Streptozotocin in an Animal Model of Sporadic AD

in Alzheimer's Disease and Related Dementias

• Jian Bao
• Yacoubou A. R. Mahaman
• Rong Liu
• Jian-Zhi Wang
• Zhiguo Zhang
• Bin Zhang
• Xiaochuan Wang

Enhanced Autolysosomal Function Ameliorates the Inflammatory Response Mediated by the NLRP3 Inflammasome in Alzheimer’s Disease

in Neuroinflammation and Neuropathy

• Wen Zhou
• Deng Xiao
• Yueyang Zhao
• Botao Tan
• Zhimin Long
• Lehua Yu
• Guiqiong He

The neuroprotective effects of Liuwei Dihuang medicine in the APP/PS1 mouse model are dependent on the PI3K/Akt signaling pathway

in Experimental Pharmacology and Drug Discovery

• Ye Yuan
• Yamei Liu
• Li Hao
• Jinlian Ma
• Simai Shao
• Ziyang Yu
• Ming Shi
• Zhenqiang Zhang
• Zijuan Zhang

Culprit or Bystander: Defective Mitophagy in Alzheimer’s Disease

in Cell Death and Survival

• Chenglong Xie
• Yahyah Aman
• Bryan A. Adriaanse
• M. Zameel Cader
• Hélène Plun-Favreau
• Jian Xiao
• Evandro F. Fang

PET Imaging in Animal Models of Alzheimer’s Disease

in Neurodegeneration

• Baosheng Chen
• Bernadette Marquez-Nostra
• Erika Belitzky
• Takuya Toyonaga
• Jie Tong
• Yiyun Huang
• Zhengxin Cai

Depletion of LncRNA NEAT1 Rescues Mitochondrial Dysfunction Through NEDD4L-Dependent PINK1 Degradation in Animal Models of Alzheimer’s Disease

in Cellular Neuropathology

• Zhonghua Huang
• Jing Zhao
• Wei Wang
• Jun Zhou
• Jie Zhang

Sensory processing deficits and related cortical pathological changes in Alzheimer’s disease

in Alzheimer's Disease and Related Dementias

• Nicole K. Zhang
• Selena K. Zhang
• Li I. Zhang
• Huizhong W. Tao
• Guang-Wei Zhang

Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer’s disease models: a systematic review and meta-analysis of preclinical studies

in Neuropharmacology

• Fanjing Kong
• Tianyu Wu
• Jingyi Dai
• Zhenwei Zhai
• Jie Cai
• Zhishan Zhu
• Ying Xu
• Tao Sun

Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease

in Brain Disease Mechanisms

• Audrey Hector
• Jonathan Brouillette

Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer’s Disease

in Neuropharmacology

• Zhao Dai
• Tian Hu
• Shijie Su
• Jinman Liu
• Yinzhong Ma
• Yue Zhuo
• Shuhuan Fang
• Qi Wang
• Zhizhun Mo
• Huafeng Pan

Alix: A Candidate Serum Biomarker of Alzheimer’s Disease

in Alzheimer's Disease and Related Dementias

• Yingni Sun
• Jin Hua
• Gen Chen
• Jianjie Li
• Jiateng Yang
• Hongwei Gao

The Neuroprotection of KIBRA in Promoting Neuron Survival and Against Amyloid β-Induced Apoptosis

in Cellular Neuropathology

• Lin Song
• Shi Tang
• Lingling Dong
• Xiaolei Han
• Lin Cong
• Jixin Dong
• Xiaojuan Han
• Qinghua Zhang
• Yongxiang Wang
• Yifeng Du

Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide hormones and novel receptor agonists protect synapses in Alzheimer’s and Parkinson’s diseases

• Christian Hölscher

Use of Fast Gamma Magnetic Stimulation Over the Left Prefrontal Dorsolateral Cortex for the Treatment of MCI and Mild Alzheimer's Disease: A Double-Blind, Randomized, Sham-Controlled, Pilot Study

in Experimental Therapeutics

• Alberto José Mimenza-Alvarado
• Sara Gloria Aguilar-Navarro
• Francisco M. Martinez-Carrillo
• Alma E. Ríos-Ponce
• Gabriel Villafuerte